Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Hamby

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Neurobiology of Disease|June 24, 2024
An interim exploratory proteomics biomarker analysis of a phase 2 clinical trial to assess the impact of CT1812 in Alzheimer's diseaseB N Lizama, H A North, K Pandey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 21, 2024
CT1812 biomarker signature from a meta-analysis of CSF proteomic findings from two Phase 2 clinical trials in Alzheimer's diseaseBritney N Lizama, Claire Williams, Hilary A North, et al.
Heart (British Cardiac Society)|March 15, 2022
Contribution of NOTCH1 genetic variants to bicuspid aortic valve and other congenital lesionsRadoslaw Marek Debiec, Stephen E Hamby, Peter D Jones, et al.
Translational Neurodegeneration|May 12, 2023
A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer's disease using an indwelling CSF catheterKelsie M LaBarbera, Yvette I Sheline, Nicholas J Izzo, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 22, 2015
Prediction of Causal Candidate Genes in Coronary Artery Disease LociIngrid Brænne, Mete Civelek, Baiba Vilne, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 9, 2021
Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modificationNicholas J Izzo, Carla M Yuede, Kelsie M LaBarbera, et al.
Acta Neuropathologica|February 6, 2024
Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer's diseaseMartí Colom-Cadena, Jamie Toombs, Elizabeth Simzer, et al.
Circulation. Genomic and Precision Medicine|May 18, 2022
Exploring the Genetic Architecture of Spontaneous Coronary Artery Dissection Using Whole-Genome SequencingIngrid Tarr, Stephanie Hesselson, Siiri E Iismaa, et al.
Nature Genetics|October 6, 2021
Polygenic basis and biomedical consequences of telomere length variationVeryan Codd, Qingning Wang, Elias Allara, et al.
Circulation. Genomic and Precision Medicine|October 30, 2020
Spontaneous Coronary Artery Dissection: Insights on Rare Genetic Variation From Genome SequencingKeren J Carss, Anna A Baranowska, Javier Armisen, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Neurobiology of Disease|June 24, 2024
An interim exploratory proteomics biomarker analysis of a phase 2 clinical trial to assess the impact of CT1812 in Alzheimer's diseaseB N Lizama, H A North, K Pandey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 21, 2024
CT1812 biomarker signature from a meta-analysis of CSF proteomic findings from two Phase 2 clinical trials in Alzheimer's diseaseBritney N Lizama, Claire Williams, Hilary A North, et al.
Heart (British Cardiac Society)|March 15, 2022
Contribution of NOTCH1 genetic variants to bicuspid aortic valve and other congenital lesionsRadoslaw Marek Debiec, Stephen E Hamby, Peter D Jones, et al.
Translational Neurodegeneration|May 12, 2023
A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer's disease using an indwelling CSF catheterKelsie M LaBarbera, Yvette I Sheline, Nicholas J Izzo, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 22, 2015
Prediction of Causal Candidate Genes in Coronary Artery Disease LociIngrid Brænne, Mete Civelek, Baiba Vilne, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 9, 2021
Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modificationNicholas J Izzo, Carla M Yuede, Kelsie M LaBarbera, et al.
Acta Neuropathologica|February 6, 2024
Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer's diseaseMartí Colom-Cadena, Jamie Toombs, Elizabeth Simzer, et al.
Circulation. Genomic and Precision Medicine|May 18, 2022
Exploring the Genetic Architecture of Spontaneous Coronary Artery Dissection Using Whole-Genome SequencingIngrid Tarr, Stephanie Hesselson, Siiri E Iismaa, et al.
Nature Genetics|October 6, 2021
Polygenic basis and biomedical consequences of telomere length variationVeryan Codd, Qingning Wang, Elias Allara, et al.
Circulation. Genomic and Precision Medicine|October 30, 2020
Spontaneous Coronary Artery Dissection: Insights on Rare Genetic Variation From Genome SequencingKeren J Carss, Anna A Baranowska, Javier Armisen, et al.
Pageof 7